10:12 PM
Tuesday 11 February 2020
–
Books – Ahmed Jumaa:
The Central Administration for Pharmaceutical Affairs of the Ministry of Health decided to seize and seize 3 medicinal preparations, which are an antibiotic and eye drops, because they do not conform to the specifications.
The Pharmacy Administration issued a leaflet No. 1 of 2020, identifying and guarding what may be found in the local market and government units of Keflex 250 mg / 5ml pos antibiotic to treat bacterial infections, including middle ear infections.
The publication clarified that the product was produced by Hikma Pharmaceutical Industries Company for operations No. 2088-2087-2086; at the request of the producing company, with the company’s representative delivering the scores and taking the pledge after breaking the seals, except in the presence of one of the pharmacy inspectors with our approval of the quantities that have been made to be executed with knowledge A committee whose members are pharmacy inspectors.
She explained that this publication was sent to the company that owns the product to freeze the assets they have from these operations and to return what was sold to pharmacies and company stores.
In another publication, Carry No. 2 of 2020, the pharmacy administration decided to seize and stimulate two travonorm 5 ml eye drop preparations, a drop for the treatment of eye allergy, produced by Orchidia Company Operations No. 0618195- 0418127-0218123-1118122-0818196-1218123 – 1218199-12121212, where It is not identical in terms of its natural properties.
It also ordered the seizure and custody of Travonorm 2.5 ml eye drop operating numbers 1118121- 0418129-0218121-0818193-0218122-0818192-0518188 as they are not identical in terms of natural properties.
The administration demanded that it provide the quantities seized from the local market and government units, freeze the existing assets and return what was sold to pharmacies and drug stores.
– .
